Cytokines: interleukin and interferon therapy in dermatology

被引:28
作者
Asadullah, K [1 ]
Sterry, W
Trefzer, U
机构
[1] Schering AG, D-13342 Berlin, Germany
[2] Humboldt Univ, Univ Hosp Charite, Dept Dermatol & Allergy, Berlin, Germany
关键词
D O I
10.1046/j.1365-2230.2002.01144.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
Cytokines are highly potent biologically active proteins that play an essential role in intercellular communication. They are vital to the mediation and regulation of inflammatory and specific immune reactions as well as to nonimmunological processes. Several cytokines are already used for the treatment of malignant, inflammatory and infectious skin diseases. This in particular includes certain interleukins (ILs) and interferons (IFNs). Whereas some cytokine therapies are already approved and well established, such as IFN-alpha and IL-2 (approved in the USA) for melanoma, others are in the early stages of development and are used in explorative trials (e. g. IL-4 and IL-10 in the treatment of psoriasis). It is likely that some of the new approaches currently under investigation will actually lead to both the registration of new drugs for dermatological treatment, and to supplementation of existing therapeutic options. The aim of this review is to give an overview on the current state of cytokine therapy in dermatology.
引用
收藏
页码:578 / 584
页数:7
相关论文
共 34 条
[1]
Asadullah K, 1999, DRUG TODAY, V35, P913
[2]
Cytokines and cutaneous T-cell lymphomas [J].
Asadullah, K ;
Docke, WD ;
Volk, HD ;
Sterry, W .
EXPERIMENTAL DERMATOLOGY, 1998, 7 (06) :314-320
[3]
Novel immunotherapies for psoriasis [J].
Asadullah, K ;
Volk, HD ;
Sterry, W .
TRENDS IN IMMUNOLOGY, 2002, 23 (01) :47-53
[4]
Cytokine therapy in dermatology [J].
Asadullah, K ;
Sterry, W ;
Trefzer, U .
EXPERIMENTAL DERMATOLOGY, 2002, 11 (02) :97-106
[5]
IL-10 is a key cytokine in psoriasis -: Proof of principle by IL-10 therapy:: A new therapeutic approach [J].
Asadullah, K ;
Sterry, W ;
Stephanek, K ;
Jasulaitis, D ;
Leupold, M ;
Audring, H ;
Volk, HD ;
Döcke, WD .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) :783-794
[6]
Effects of systemic interleukin-10 therapy on psoriatic skin lesions:: Histologic, immunohistologic, and molecular biology findings [J].
Asadullah, K ;
Friedrich, M ;
Hanneken, S ;
Rohrbach, C ;
Audring, H ;
Vergopoulos, A ;
Ebeling, M ;
Döcke, WD ;
Volk, HD ;
Sterry, W .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 116 (05) :721-727
[7]
Interleukin 10 treatment of psoriasis -: Clinical results of a phase 2 trial [J].
Asadullah, K ;
Döcke, WD ;
Ebeling, M ;
Friedrich, M ;
Belbe, G ;
Audring, H ;
Volk, HD ;
Sterry, W .
ARCHIVES OF DERMATOLOGY, 1999, 135 (02) :187-192
[8]
Interleukin-10 in cutaneous disorders:: implications for its pathophysiological importance and therapeutic use [J].
Asadullah, K ;
Sabat, R ;
Wiese, A ;
Döcke, WD ;
Volk, HD ;
Sterry, W .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1999, 291 (12) :628-636
[9]
INTRALESIONAL INTERFERON THERAPY FOR BASAL-CELL CARCINOMA [J].
CORNELL, RC ;
GREENWAY, HT ;
TUCKER, SB ;
EDWARDS, L ;
ASHWORTH, S ;
VANCE, JC ;
TANNER, DJ ;
TAYLOR, EL ;
SMILES, KA ;
PEETS, EA .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1990, 23 (04) :694-700
[10]
Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma [J].
Dippel, E ;
Schrag, H ;
Goerdt, S ;
Orfanos, CE .
LANCET, 1997, 350 (9070) :32-33